BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33529294
Number of visits today
1709
Number of downloads
16715381
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Cha JH, Jang JS. Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. Turk J Gastroenterol 2020;31:36-41. [PMID: 32009612 DOI: 10.5152/tjg.2020.18764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fang X, Xu J, Jin K, Qian J. Combining of immunotherapeutic approaches with chemotherapy for treatment of gastric cancer: Achievements and limitations. Int Immunopharmacol 2023;118:110062. [PMID: 36965367 DOI: 10.1016/j.intimp.2023.110062] [Reference Citation Analysis]
2 Zhao H, Ding Y, Zhang L. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis. Open Med (Wars) 2023;18:20220620. [PMID: 36820068 DOI: 10.1515/med-2022-0620] [Reference Citation Analysis]
3 Kim DH. Is a Biopsy Required for All Ulcer Scars after Endoscopic Submucosal Dissection of Gastric Neoplasia? Korean J Helicobacter Up Gastrointest Res 2021;21:1-3. [DOI: 10.7704/kjhugr.2020.0066] [Reference Citation Analysis]
4 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 2020;39:1179-203. [PMID: 32894370 DOI: 10.1007/s10555-020-09925-3] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 31.7] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345